In pancreatic ductal adenocarcinoma, silencing ALKBH5 can promote malignant biological behaviors of cancer cells, and also promote the drug resistance of cancer cells to chemotherapy. This evidence concerns the gene ALKBH5 and pancreatic ductal adenocarcinoma.